IM-12   Click here for help

GtoPdb Ligand ID: 8017

Compound class: Synthetic organic
Comment: IM-12 is a selective inhibitor of glycogen synthase kinase-3β (GSK-3β) [8].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 65.2
Molecular weight 377.15
XLogP 4.06
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Fc1ccc(cc1)CCNC1=C(C(=O)N(C1=O)C)c1c(C)[nH]c2c1cccc2
Isomeric SMILES Fc1ccc(cc1)CCNC1=C(C(=O)N(C1=O)C)c1c(C)[nH]c2c1cccc2
InChI InChI=1S/C22H20FN3O2/c1-13-18(16-5-3-4-6-17(16)25-13)19-20(22(28)26(2)21(19)27)24-12-11-14-7-9-15(23)10-8-14/h3-10,24-25H,11-12H2,1-2H3
InChI Key ZKJAZFUFPPSFCO-UHFFFAOYSA-N
No information available.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
GSK-3 negatively regulates several aspects of insulin signalling, and upregulated GSK-3 activity may be involved in the development of insulin resistance in type 2 diabetes [3,7] and in neurodegenerative disease [1,5,9]. GSK-3 inhibitors have therefore become the focus of intense drug discovery efforts.
The Wnt signalling pathway is involved in neural stem cell differentiation, mediating the processes of migration [2], synaptogenesis [4], axon guidance [6] and neural induction [10]. GSK-3β inhibition induces decreased activity of the β-catenin degradation complex, thus stabilising β-catenin and mediates increased Wnt signalling. This ultimately leads to increased neurogenesis.